1 active not recruiting, 1 completed, 1 enrolling by invitation, 1 recruiting. 1 Early Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Recruiting 1 |
| Phase 3 | 1 | Completed 1 |
Follow Averitas Pharma, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Exploring the Benefit of Topical Capsaicin in Treating Pain From Chemo-induced Peripheral Neuropathy: a Longitudinal Single Center Pilot Study Qutenza Patch - Peripheral Neuropathy Due to Chemotherapy | Early Phase 1 | Recruiting | M.D. Anderson Cancer Center | 20 | 2025-12-11 | 2026-06-26 |
| Observational Study to Evaluate the Efficacy of Sustained QUTENZA® Use in Painful Diabetic Peripheral Neuropathy Capsaicin 8% - Peripheral Diabetic Neuropathy, Painful Diabetic Neuropathy | Active not recruiting | Averitas Pharma, Inc. | 144 | 2025-03-14 | 2026-07-13 | |
| Qutenza 8% Capsaicin Topical System for the Treatment of Neuropathic Axial Lower Back Pain and Lumbosacral Radiculopathy Qutenza® 8% Capsaicin Topical System - Lower Back Pain, Lumbosacral Radiculopathy | Enrolling by invitation | Medical University of South Carolina | 50 | 2025-03-13 | 2026-03-20 | |
| Comparison of Qutenza (8% Capsaicin) With a Low-dose Capsaicin for Treatment of Nerve Pain After Surgery Qutenza (capsaicin) 8% topical system, capsaicin 0.04% topical system - Post Surgical Neuropathic Pain | Phase 3 | Completed | Averitas Pharma, Inc. | 412 | 2021-07-13 | 2026-09-21 |
Diabetic Neuropathies (1) · Low Back Pain (1)
Capsaicin (3) · Drug Delivery Systems (1)
United States (4) · France (1) · Netherlands (1) · Poland (1) · Spain (1) · United Kingdom (1)
Matthew Sherrier (1) · Saba Javed, MD (1)